Evidence map›Paper›PMID 40917564›Full record

ArticleJournal of diabetes and metabolic disorders2025

NICTH with secondary acromegaloid changes and severe hypoglycemia due to potentially insulin-like growth factor-2 mediated effects.

Mahdieh Fatollahzadeh, Hamid Pajavand, Mahdis Khazaeli Najafabadi, Hamid Reza Aghaei Meybodi

Abstract readCase Reports
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mahdieh FatollahzadehEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Hamid PajavandDepartment of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.ORCID https://orcid.org/0000-0003-0287-445X
Mahdis Khazaeli NajafabadiDepartment of Pathology, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hamid Reza Aghaei MeybodiEvidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-1754-3450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome resulting from excessive secretion of pro-insulin-like growth factor 2 (proIGF-2). This leads to hypoinsulinemic hypoglycemia and, in some cases, acromegaly. We report the case of a 52-year-old woman with NICTH syndrome who had decreased levels of insulin-like growth factor 1 (IGF1), insulin, C-peptide, and growth hormone (GH). The patient experienced severe hypoglycemia, with blood glucose levels dropping to 42 mg/dL (normal reference range; 70-100 mg/dL and SI unit; 2.33 mmol/L), resulting in tachycardia, palpitations, and confusion. Additionally, the patient exhibited acromegaloid features, such as a coarse facial appearance and hyperpigmentation. The patient presented with shortness of breath and chest pain. A mass was found in her left lung, which was successfully removed through thoracotomy surgery, resolving her hypoglycemic symptoms.

Indexed as

AcromegalyHypoglycemiaNon-islet cell tumor hypoglycemia (NICTH)Pro-insulin-like growth factor 2 (proIGF-2)

Identifiers

PMID40917564
PMCPMC12408436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.